These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 4927028

  • 1. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A, Foradori A, Eyzaguirre J, Lira P, Vasquez A, Soto S, Alliende ME, Guzman L.
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract] [Full Text] [Related]

  • 2. Effects of CH 13.437 in different types of hyperlipidemia.
    Harvengt C.
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:298+. PubMed ID: 4559547
    [No Abstract] [Full Text] [Related]

  • 3. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids.
    Best MM, Duncan CH.
    Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616
    [No Abstract] [Full Text] [Related]

  • 4. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML, Setty KR, Roy SB.
    J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418
    [No Abstract] [Full Text] [Related]

  • 5. [Therapeutic effect of Ciba 13437-Su in 40 patients with familial essential hyperlipemia].
    Schönbeck M, Forster G, Hirzel H, Jakab T, Rosenmund H.
    Dtsch Med Wochenschr; 1970 Aug 28; 95(35):1761-8. PubMed ID: 5451984
    [No Abstract] [Full Text] [Related]

  • 6. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P, Motolese M, Cerqua R, Mancini M.
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct 28; 2(4):348-53. PubMed ID: 4903988
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of diet changes and use of dextrothyroxine and chlorphenisate on serum lipids].
    Arteaga A, Cisternas H, Torres MC, Alliende ME.
    Rev Med Chil; 1969 May 28; 97(5):285-90. PubMed ID: 5386042
    [No Abstract] [Full Text] [Related]

  • 8. The efficacy of lipid lowering drugs alone and in combination.
    Hansen PF.
    Postgrad Med J; 1975 May 28; 51(8):63-5. PubMed ID: 768949
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of primitive hyperlipidemias with a tetralin derivative].
    Fellin R, Fedele D, Bagnariol G, Pagnan A, Crepaldi G.
    G Ital Cardiol; 1972 May 28; 2(6):863-70. PubMed ID: 4564549
    [No Abstract] [Full Text] [Related]

  • 10. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
    Malhotra SC, Ahuja MM.
    Indian J Med Res; 1971 Oct 28; 59(10):1621-32. PubMed ID: 5159000
    [No Abstract] [Full Text] [Related]

  • 11. [Arteriosclerosis--nicotinic acid therapy. 10. Combination therapy in hyperlipemia].
    Hansen PF.
    Lakartidningen; 1971 Apr 07; 68(15):1769-72. PubMed ID: 5577252
    [No Abstract] [Full Text] [Related]

  • 12. Growth and luteinizing hormone decreases during nafenoic acid therapy.
    Danowski TS, Fisher ER, Gonzalez AR, Khurana RC, Jung Y, Hancock RA, Vester JW.
    Pol Med Sci Hist Bull; 1971 Oct 07; 14(4):148-53. PubMed ID: 5131072
    [No Abstract] [Full Text] [Related]

  • 13. Biphenabid (Probucol): a new hypocholesterolemic agent.
    Kalams Z, Dacquisto M, Kornett GS.
    Curr Ther Res Clin Exp; 1971 Nov 07; 13(11):692-4. PubMed ID: 5000716
    [No Abstract] [Full Text] [Related]

  • 14. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A, Manninen V.
    Proc R Soc Med; 1976 Nov 07; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract] [Full Text] [Related]

  • 15. [Action of the new hypocholesteremic agent DH-581 (dithiobisphenol) in humans].
    Brusco OJ, Oriozabala MA, Arakaki R.
    Prensa Med Argent; 1971 Oct 08; 58(32):1587-94. PubMed ID: 4943247
    [No Abstract] [Full Text] [Related]

  • 16. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C, Quadri A, Ratti S, Levi GF, Prandini BD.
    G Ital Cardiol; 1978 Oct 08; 8(7):743-51. PubMed ID: 355033
    [Abstract] [Full Text] [Related]

  • 17. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H, Jaillard J.
    Lille Med; 1968 Jan 08; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of essential hyperlipidaemia.
    Fredrickson DS, Levy RI.
    Lancet; 1970 Jan 24; 1(7639):191-2. PubMed ID: 4189261
    [No Abstract] [Full Text] [Related]

  • 19. [Hepatotoxic effects of 2-methyl-2-(p-(1,2,3,4-tetrahydro-1-naphthyl)-phenoxy)propionic acid (Ciba 13,437-Su)].
    Kattermann R, Arnold R, Creutzfeldt W.
    Arzneimittelforschung; 1972 Mar 24; 22(3):616-9. PubMed ID: 4624899
    [No Abstract] [Full Text] [Related]

  • 20. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N.
    Acta Med Scand; 1970 Mar 03; 187(3):213-8. PubMed ID: 5444978
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.